Method for Designing and Characterizing Phototherapy Shields

Tyler W. Iorizzo
Advanced Biophotonics Laboratory, University of Massachusetts Lowell, MA, USA

Javed Mannan
University of Massachusetts Medical School, Worcester, MA, USA

Anna N. Yaroslavsky (Login required)
Advanced Biophotonics Laboratory, University of Massachusetts Lowell, MA, USA

Paper #3472 received 24 Jan 2022; revised manuscript received 09 May 2022; accepted for publication 22 Jun 2022; published online 5 Jul 2022.

DOI: 10.18287/JBPE22.08.030301


Optimal shield properties and design are of vital importance for preventing adverse effects of light-based clinical procedures. The goal of this study was to select the most appropriate materials for a two-layer phototherapy shield. Four biocompatible fabrics, to be utilized as the layer contacting patients’ skin, and two reflective materials, to be utilized as the layer facing the light source, were investigated. The optical properties of the four biocompatible fabrics and transmittance of the two reflective materials were determined in the 400–500 nm range. Absorption coefficient, scattering coefficient, and anisotropy factors of biocompatible fabrics were determined using integrating sphere spectrophotometry and an inverse Monte Carlo method. Fabric and reflective materials that exhibited highest attenuation of the blue light were selected to assemble a two-layer composite prototype. Prototypes were exposed to blue light emitted from a clinical source to ensure negligible temperature increase under clinically relevant exposure conditions. A protype blue-light phototherapy shield was made from two test materials, both of which provide sufficient light attenuation to provide patient protection. The testing method employed in this study may prove valuable for designing protective gear for a range of clinical procedures.


phototherapy; integrating sphere spectrophotometry; phototherapy shielding

Full Text:



1. L. A. Stokowski, “Fundamentals of Phototherapy for Neonatal Jaundice,” Advances in Neonatal Care 11(5S), S10–S21 (2013).

2. Z. Csoma, E. Tóth-Molnár, K. Balogh, H. Polyánka, H. Orvos, H. Ócsai, L. Kemény, M. Széll, and J. Oláh, “Neonatal Blue Light Phototehrapy and Melanocytic Nevi: A Twin Study,” Pediatrics 128(4), e856–e864 (2011).

3. B. F. Godley, F. Shamsi, F.-Q. Liang, S. G. Jarrett, S. Davies, and M. Boulton, “Blue Light Induces Mitochondrial DNA Damage and Free Radical Production in Epithelial Cells,” Journal of Biological Chemistry 280(22), 21061–21066 (2005).

4. S. Vandersee, M. Beyer, J. Lademann, and M. E. Darvin, “Blue-Violet Light Irradiation Dose Dependently Decreases Carotenoids in Human Skin, Which Indicates the Generation of Free Radicals,” Oxidative Medicine and Cellular Longevity 2015, 579675 (2015).

5. Y. Nakashima, S. Ohta, and A. M.Wolf, “Blue light-induced oxidative stress in live skin,” Free Radical Biology and Medicine 108, 300–310 (2017).

6. J. G. Coats, B. Maktabi, M. S. Abou-Dahech, and G. Baki, “Blue Light Protection, Part 1 – Effects of blue light on the skin,” Journal of Cosmetic Dermatology 20(3), 714–717 (2021).

7. S. A. Holme, A. V. Anstey, “Phototherapy and PUVA photochemotherapy in children,” Photodermatology Photoimmunology and Photomedicine 20(2), 69–75 (2004).

8. P. Komericki, P. Fellner, Y. El-Shabrawi, and N. Ardjomand, “Keratopathy after ultraviolet B phototherapy,” Wiener Klinische Wochenschrift 117(7–8), 300–302 (2005).

9. G. Javey, S. G. Schwartz, and T. A. Albini, “Ocular Complication of Intense Pulsed Light Therapy: Iris Photoablation,” Dermatologic Surgery 36(9), 1446–1468 (2010).

10. M. Crabb, W. O. Chan, D. Taranath, and S. C. Huilgol, “Intense pulsed light therapy (IPL) induced iritis following treatment for a medial canthal capillary malformation,” Australasian Journal of Dermatology 55(4), 289–291 (2014).

11. W. Rosenfield, S. Sadhev, V. Brunot, R. Jhaveri, I. Zabaleta, and H. E. Evans, “Phototherapy Effect on the Incidence of Patent Ductus Arteriosus in Premature Infants: Prevention With Chest Shielding,” Pediatrics 78(1), 10–14 (1986).

12. H. S. Kim, E.-K. Kim, H.-E. Lee, Y.-K. Lee, C.-H. Park, K.-R. Park, J.-D. Park, B.-I. Kim, W.-H. Kim, J.-H. Choi, Y.-S. Yun, C.-K. Yun, and J.-M. Lee, “Influence of Phototherapy on Incidence of Patent Ductus Arteriosus in Very Low Birth Weight Infants,” Journal of the Korean Pediatric Society 40(10), 1410–1418 (1997).

13. L. G. Henyey, J. L. Greenstein, “Diffuse radiation in the Galaxy,” Astrophysical Journal 93, 70–83 (1941).

14. I. V. Yaroslavsky, A. N. Yaroslavsky, T. Goldbach, and H.-J. Schwarzmaier, “Inverse hybrid technique for determining the optical properties of turbid media from integrating-sphere measurements,” Applied Optics 35(34), 6797–6809 (1996).

15. J. E. Dennis, R. B. Schnabel, Numerical Methods for Unconstrained Optimization and Nonlinear Equations, Prentice-Hall, Upper Saddle River (1983).

16. K. C. Chin, M. J. Moseley, and S. C. Bayliss, “Light transmission of phototherapy eyeshields,” Archives of Disease in Childhood 62, 970–971 (1987).

17. J. Robinson, M. J. Moseley, A. R. Fielder, and S. C. Bayliss, “Light transmission measurements and phototherapy eyepatches,” Archives of Disease in Childhood 66, 59–61 (1991).

18. S. G. H. Otman, L. D. El-Dars, C. Edwards, E. Ansari, D. Taylor, B. Gambles, I. Chalmers, and A. V. Anstey, “Eye protection for ultraviolet B phototherapy and psoralen ultraviolet A patients,” Photodermatology Photoimmunology and Photomedicine 26(3), 143–150 (2010).

19. F. R. Abdulla, C. Breneman, B. Adams, and D. Breneman, “Standards for genital protection in phototherapy units,” Journal of the American Academy of Dermatology 62(2), 223–226 (2010).

20. S. L. Jacques, M. O. Gaeeni, “Thermically induced changes in optical properties of heart,” Images of the Twenty-First Century. Proceedings of the Annual International Engineering in Medicine and Biology Society 4, 1199–1200 (1989).

21. A. N. Yaroslavsky, P. C. Schulze, I. V. Yaroslavsky, R. Schober, F. Ulrich, and H.-J. Schwarzmaier, “Optical properties of selected native and coagulated human brain tissues in vitro in the visible and near infrared spectral range,” Physics in Medicine & Biology 47(12), 2059–2073 (2002).

22. A. N. Bashkatov, E. A. Genina, V. I. Kochubey, and V. V. Tuchin, “Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm,” Journal of Physics D: Applied Physics 38, 2543 (2005).

23. E. Salomatina, B. Jiang, J. Novak, and A. N. Yaroslavsky, “Optical properties of normal and cancerous human skin in the visible and near-infrared spectral range,” Journal of Biomedical Optics 11(6), 064026 (2006).

© 2014-2021 Samara National Research University. All Rights Reserved.
Public Media Certificate (RUS). 12+